CLINICAL_TRIALS
trial_result
· 2018-10-01
Clinical Trial Update: AZD0585 Phase III Long-term Study in Japan [Phase 3]
Summary
Phase III long-term study in Japan for AZD0585 in hypertriglyceridemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2018-10-01